These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 15325438

  • 21. [Quinolone resistance in Salmonella enterica].
    Seral C, López L, Castillo FJ, Clavel A, Rubio MC.
    Rev Esp Quimioter; 1998 Mar; 11(1):43-6. PubMed ID: 9795288
    [Abstract] [Full Text] [Related]

  • 22. Reduced susceptibility to ciprofloxacin and gyra gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A.
    Renuka K, Kapil A, Kabra SK, Wig N, Das BK, Prasad VV, Chaudhry R, Seth P.
    Microb Drug Resist; 2004 Mar; 10(2):146-53. PubMed ID: 15256030
    [Abstract] [Full Text] [Related]

  • 23. Antibiotic susceptibility pattern and the indicator of decreased ciprofloxacin susceptibility of Salmonella enterica serovar Typhi isolated from Dhulikhel Hospital, Nepal.
    Acharya D, Trakulsomboon S, Madhup SK, Korbsrisate S.
    Jpn J Infect Dis; 2012 Mar; 65(3):264-7. PubMed ID: 22627312
    [Abstract] [Full Text] [Related]

  • 24. In vitro fluoroquinolone-resistant mutants of Salmonella enterica serotype Enteritidis: analysis of mechanisms involved in resistance.
    Soto SM, Ruíz J, Mendoza MC, Vila J.
    Int J Antimicrob Agents; 2003 Nov; 22(5):537-40. PubMed ID: 14602375
    [Abstract] [Full Text] [Related]

  • 25. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
    Kehrenberg C, de Jong A, Friederichs S, Cloeckaert A, Schwarz S.
    J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276
    [Abstract] [Full Text] [Related]

  • 26. Comparison of gyrA mutations, cyclohexane resistance, and the presence of class I integrons in Salmonella enterica from farm animals in England and Wales.
    Liebana E, Clouting C, Cassar CA, Randall LP, Walker RA, Threlfall EJ, Clifton-Hadley FA, Ridley AM, Davies RH.
    J Clin Microbiol; 2002 Apr; 40(4):1481-6. PubMed ID: 11923377
    [Abstract] [Full Text] [Related]

  • 27. Complete nucleotide sequence of the gyrA gene of Helicobacter pullorum and identification of a point mutation leading to ciprofloxacin resistance in poultry isolates.
    Pasquali F, Rossi M, Manfreda G, Zanoni R.
    Int J Antimicrob Agents; 2007 Sep; 30(3):222-8. PubMed ID: 17644320
    [Abstract] [Full Text] [Related]

  • 28. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
    Eraç B, Gill A, Amyes SG, Gülay Z.
    Mikrobiyol Bul; 2003 Sep; 37(2-3):125-30. PubMed ID: 14593893
    [Abstract] [Full Text] [Related]

  • 29. Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates.
    Capilla S, Ruiz J, Goñi P, Castillo J, Rubio MC, Jiménez de Anta MT, Gómez-Lus R, Vila J.
    J Antimicrob Chemother; 2004 Jun; 53(6):1068-71. PubMed ID: 15117921
    [Abstract] [Full Text] [Related]

  • 30. Presence of plasmid-mediated quinolone resistance determinants and mutations in gyrase and topoisomerase in Salmonella enterica isolates with resistance and reduced susceptibility to ciprofloxacin.
    Casas MR, Camargo CH, Soares FB, da Silveira WD, Fernandes SA.
    Diagn Microbiol Infect Dis; 2016 May; 85(1):85-9. PubMed ID: 26971183
    [Abstract] [Full Text] [Related]

  • 31. Nalidixic acid resistance in Salmonella strains with decreased susceptibility to ciprofloxacin isolated from humans in Turkey.
    Ercis S, Erdem B, Hasçelik G, Gür D.
    Jpn J Infect Dis; 2006 Apr; 59(2):117-9. PubMed ID: 16632912
    [Abstract] [Full Text] [Related]

  • 32. Effect of a 5 day enrofloxacin treatment on Salmonella enterica serotype Typhimurium DT104 in the pig.
    Delsol AA, Woodward MJ, Roe JM.
    J Antimicrob Chemother; 2004 Feb; 53(2):396-8. PubMed ID: 14711838
    [Abstract] [Full Text] [Related]

  • 33. Salmonella enterica serovar Kentucky: antimicrobial resistance and molecular analysis of clinical isolates from the Slovak Republic.
    Majtán V, Majtán T, Majtán J, Szabóová M, Majtánová L.
    Jpn J Infect Dis; 2006 Dec; 59(6):358-62. PubMed ID: 17186952
    [Abstract] [Full Text] [Related]

  • 34. Geographically dependent distribution of gyrA gene mutations at codons 83 and 87 in Salmonella Hadar, and a novel codon 81 Gly to His mutation in Salmonella Enteritidis.
    Lindstedt BA, Aas L, Kapperud G.
    APMIS; 2004 Mar; 112(3):165-71. PubMed ID: 15153158
    [Abstract] [Full Text] [Related]

  • 35. Antimicrobial resistance in clinical isolates of Salmonella enterica serotype Enteritidis: relationships between mutations conferring quinolone resistance, integrons, plasmids and genetic types.
    Soto SM, González-Hevia MA, Mendoza MC.
    J Antimicrob Chemother; 2003 May; 51(5):1287-91. PubMed ID: 12668577
    [Abstract] [Full Text] [Related]

  • 36. [Resistance to quinolones and beta-lactams in Salmonella enterica due to mutations in topoisomerase-encoding genes, altered cell permeability and expression of an active efflux system].
    Miró E, Vergés C, García I, Mirelis B, Navarro F, Coll P, Prats G, Martínez-Martínez L.
    Enferm Infecc Microbiol Clin; 2004 Apr; 22(4):204-11. PubMed ID: 15056435
    [Abstract] [Full Text] [Related]

  • 37. Mutant prevention concentrations of ciprofloxacin and enrofloxacin for Salmonella enterica.
    Randall LP, Cooles SW, Piddock LJ, Woodward MJ.
    J Antimicrob Chemother; 2004 Sep; 54(3):688-91. PubMed ID: 15243029
    [Abstract] [Full Text] [Related]

  • 38. Two distinct mutations in gyrA lead to ciprofloxacin and nalidixic acid resistance in Campylobacter coli and Campylobacter jejuni isolated from chickens and beef cattle.
    Jesse TW, Englen MD, Pittenger-Alley LG, Fedorka-Cray PJ.
    J Appl Microbiol; 2006 Apr; 100(4):682-8. PubMed ID: 16553723
    [Abstract] [Full Text] [Related]

  • 39. Characterization of the quinolone resistance mechanism in foodborne Salmonella isolates with high nalidixic acid resistance.
    Kim KY, Park JH, Kwak HS, Woo GJ.
    Int J Food Microbiol; 2011 Mar 15; 146(1):52-6. PubMed ID: 21354645
    [Abstract] [Full Text] [Related]

  • 40. Molecular analysis of high-level ciprofloxacin resistance in Salmonella enterica serovar Typhi and S. Paratyphi A: need to expand the QRDR region?
    Capoor MR, Nair D, Walia NS, Routela RS, Grover SS, Deb M, Aggarwal P, Pillai PK, Bifani PJ.
    Epidemiol Infect; 2009 Jun 15; 137(6):871-8. PubMed ID: 18687156
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.